Cargando…
HER2 inhibition increases non-muscle myosin IIA to promote tumorigenesis in HER2+ breast cancers
HER2 is over-expressed in around 15% to 20% of breast cancers. HER3 plays a critical role in HER2 mediated tumorigenesis. Increased HER3 transcription and protein levels occur upon inhibition of HER2. We aimed to identify proteins that bound to HER3 upon inhibition of the HER family with the pan-HER...
Autores principales: | Alanazi, Samar M., Feroz, Wasim, Mishra, Rosalin, Kilroy, Mary Kate, Patel, Hima, Yuan, Long, Storr, Sarah J., Garrett, Joan T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10194889/ https://www.ncbi.nlm.nih.gov/pubmed/37200287 http://dx.doi.org/10.1371/journal.pone.0285251 |
Ejemplares similares
-
HER3 Alterations in Cancer and Potential Clinical Implications
por: Kilroy, Mary Kate, et al.
Publicado: (2022) -
HER3 signaling and targeted therapy in cancer
por: Mishra, Rosalin, et al.
Publicado: (2018) -
PI3K Inhibitors in Cancer: Clinical Implications and Adverse Effects
por: Mishra, Rosalin, et al.
Publicado: (2021) -
IGF1R/IR Mediates Resistance to BRAF and MEK Inhibitors in BRAF-Mutant Melanoma
por: Patel, Hima, et al.
Publicado: (2021) -
Activating HER3 mutations in breast cancer
por: Mishra, Rosalin, et al.
Publicado: (2018)